- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Important, 18-12-2025: Updates
18-12-2025 | 05:44 pm
18-12-2025 | 05:44 pm
Biocon's Cranbury generics facility received a favorable US FDA inspection report, with a 'Voluntary Action Indicated' (VAI) status. This means observations were made, but no further regulatory action is required, highlighting continued operational compliance.
No comments yet. Be the first to comment!